Literature DB >> 31337255

SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.

María Galindo-Moreno1, Servando Giráldez1,2, M Cristina Limón-Mortés1, Alejandro Belmonte-Fernández1, Steven I Reed2, Carmen Sáez3,4, Miguel Á Japón3,4, Maria Tortolero1, Francisco Romero1.   

Abstract

Eukaryotic cells have developed sophisticated mechanisms to ensure the integrity of the genome and prevent the transmission of altered genetic information to daughter cells. If this control system fails, accumulation of mutations would increase risk of diseases such as cancer. Ubiquitylation, an essential process for protein degradation and signal transduction, is critical for ensuring genome integrity as well as almost all cellular functions. Here, we investigated the role of the SKP1-Cullin-1-F-box protein (SCF)-[F-box and tryptophan-aspartic acid (WD) repeat domain containing 7 (FBXW7)] ubiquitin ligase in cell proliferation by searching for targets implicated in this process. We identified a hitherto-unknown FBXW7-interacting protein, p53, which is phosphorylated by glycogen synthase kinase 3 at serine 33 and then ubiquitylated by SCF(FBXW7) and degraded. This ubiquitylation is carried out in normally growing cells but primarily after DNA damage. Specifically, we found that SCF(FBXW7)-specific targeting of p53 is crucial for the recovery of cell proliferation after UV-induced DNA damage. Furthermore, we observed that amplification of FBXW7 in wild-type p53 tumors reduced the survival of patients with breast cancer. These results provide a rationale for using SCF(FBXW7) inhibitors in the treatment of this subset of tumors.-Galindo-Moreno, M., Giráldez, S., Limón-Mortés, M. C., Belmonte-Fernández, A., Reed, S. I., Sáez, C., Japón, M. Á., Tortolero, M., Romero, F. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.

Entities:  

Keywords:  FBXW7 inhibitors; cancer; proliferation; ubiquitylation

Mesh:

Substances:

Year:  2019        PMID: 31337255      PMCID: PMC6766643          DOI: 10.1096/fj.201900885R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  53 in total

Review 1.  Ubiquitin ligases: cell-cycle control and cancer.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

2.  Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.

Authors:  Frank van Drogen; Olle Sangfelt; Aljona Malyukova; Ludmila Matskova; Elizabeth Yeh; Anthony R Means; Steven I Reed
Journal:  Mol Cell       Date:  2006-07-07       Impact factor: 17.970

3.  Distinct phosphatases antagonize the p53 response in different phases of the cell cycle.

Authors:  Indra A Shaltiel; Melinda Aprelia; Adrian T Saurin; Dipanjan Chowdhury; Geert J P L Kops; Emile E Voest; René H Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

4.  Regulation of the yeast HO gene.

Authors:  L Breeden; K Nasmyth
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1985

Review 5.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

6.  Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line.

Authors:  H Strohmaier; C H Spruck; P Kaiser; K A Won; O Sangfelt; S I Reed
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

7.  Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

Authors:  P M O'Connor; J Jackman; I Bae; T G Myers; S Fan; M Mutoh; D A Scudiero; A Monks; E A Sausville; J N Weinstein; S Friend; A J Fornace; K W Kohn
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

8.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Authors:  Markus Welcker; Amir Orian; Jianping Jin; Jonathan E Grim; Jonathan A Grim; J Wade Harper; Robert N Eisenman; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

9.  Role of Pirh2 in mediating the regulation of p53 and c-Myc.

Authors:  Anne Hakem; Miyuki Bohgaki; Bénédicte Lemmers; Elisabeth Tai; Leonardo Salmena; Elzbieta Matysiak-Zablocki; Yong-Sam Jung; Jana Karaskova; Lilia Kaustov; Shili Duan; Jason Madore; Paul Boutros; Yi Sheng; Marta Chesi; P Leif Bergsagel; Bayardo Perez-Ordonez; Anne-Marie Mes-Masson; Linda Penn; Jeremy Squire; Xinbin Chen; Igor Jurisica; Cheryl Arrowsmith; Otto Sanchez; Samuel Benchimol; Razqallah Hakem
Journal:  PLoS Genet       Date:  2011-11-17       Impact factor: 5.917

Review 10.  Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.

Authors:  Sanam Sane; Khosrow Rezvani
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

View more
  7 in total

1.  Comparing cell-free circulating tumor DNA mutational profiles of disease-free and nonresponders patients with oropharyngeal squamous cell carcinoma.

Authors:  Alok R Khandelwal; Adam H Greer; Mickie Hamiter; Janmaris Marin Fermin; Thomas McMullen; Tara Moore-Medlin; Glenn Mills; Jose M Flores; Hong Yin; Cherie-Ann O Nathan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-09-01

Review 2.  F-Box Proteins and Cancer.

Authors:  Kanae Yumimoto; Yuhei Yamauchi; Keiichi I Nakayama
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

3.  p53 and FBXW7: Sometimes Two Guardians Are Worse than One.

Authors:  María Galindo-Moreno; Servando Giráldez; M Cristina Limón-Mortés; Alejandro Belmonte-Fernández; Carmen Sáez; Miguel Á Japón; Maria Tortolero; Francisco Romero
Journal:  Cancers (Basel)       Date:  2020-04-16       Impact factor: 6.639

4.  A Comprehensive Assessment of Genetic and Epigenetic Alterations Identifies Frequent Variations Impacting Six Prototypic SCF Complex Members.

Authors:  Rubi Campos Gudiño; Ally C Farrell; Nicole M Neudorf; Kirk J McManus
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

5.  FBXW7 inactivation induces cellular senescence via accumulation of p53.

Authors:  Longyuan Gong; Danrui Cui; Dian Liu; Xiao Shen; Hui Pan; Xiufang Xiong; Yongchao Zhao
Journal:  Cell Death Dis       Date:  2022-09-14       Impact factor: 9.685

6.  Downregulated F-Box/LRR-Repeat Protein 7 Facilitates Pancreatic Cancer Metastasis by Regulating Snail1 for Proteasomal Degradation.

Authors:  Liang Tang; Meng Ji; Xing Liang; Danlei Chen; Anan Liu; Guang Yang; Ligang Shi; Zhiping Fu; Chenghao Shao
Journal:  Front Genet       Date:  2021-06-24       Impact factor: 4.599

7.  A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis.

Authors:  Jun Zeng; Xiao-Qing Xiao; Zhi-Yong Zhou
Journal:  Cancer Res Treat       Date:  2021-06-29       Impact factor: 5.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.